Caribou Biosciences (CRBU) Financials: Revenue & Earnings

CRBU price $0.47 +0.01 +3.04%

Ticker
CRBU
Price
$0.47
Change
+0.01 +3.04%
Market cap ?
$50.89M
P/E ?
-0.44
Dividend yield ?
0.00%
Beta ?
2.31
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
60
Value
58
Quality
46
Growth
77

Stocklytics score rationale: value 58, quality 46, growth 77.

Financials

2019202020212022202320242025
57880001236100095980001385100034477000999400011159000

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving patients across the United States and internationally. Among its primary therapeutic candidates are CB-010, an allogeneic anti-CD19 CAR-T cell…

Fair value

CRBU fair value Not meaningful. Price $0.47.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare CRBU

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.27—1.60M
2026-08-13-0.24-0.321.50M2.28M
2026-05-07-0.26-0.332.40M2.21M
2026-03-05-0.28-0.333.94M2.21M
2025-11-12-0.30-0.362.20M1.96M
2025-08-12-0.35-0.402.67M1.53M
2025-05-08-0.43-0.432.35M1.85M
2025-03-10-0.39-0.402.08M2.11M
2024-11-06-0.38-0.442.02M3.08M
2024-08-06-0.42-0.453.46M3.05M
2024-05-07-0.46-0.392.43M2.42M
2024-03-11-0.39-0.223.56M3.95M
2023-11-07-0.12-0.3823.66M3.29M
2023-08-08-0.48-0.493.75M3.08M
2023-05-09-0.46-0.483.50M2.75M
2023-03-09-0.44-0.473.69M3.07M
2022-11-08-0.44-0.483.30M3.70M
2022-08-09-0.44-0.364.19M2.86M
2022-05-09-0.35-0.352.66M3.20M
2022-03-21-0.34-0.342.56M4.17M
2021-11-09-0.46-0.123.98M16.50M
2021-09-02-1.550.421.48M—
2021-07-23-0.48—1.59M—
2020-12-31-0.53—984.00K—
2020-09-30-0.29—1.20M—
2020-06-30-0.07—8.48M—
2020-03-31-0.35—1.70M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-02-25Kelly Timothy PSell6.23K$1.9312.02K
2026-02-24Kelly Timothy PSell3.15K$1.966.17K
2026-02-24MCCLUNG BARBARA GSell6.94K$1.9613.60K
2026-02-24Khan Ruhi AhmadSell6.94K$1.9613.60K
2026-02-24Albertson Tina M.Sell1.07K$1.962.09K
2026-02-20Kelly Timothy PBuy202.50K$1.80364.50K
2026-02-20Kelly Timothy PBuy45.00K——
2026-02-20MCCLUNG BARBARA GBuy45.00K——
2026-02-20MCCLUNG BARBARA GBuy202.50K$1.80364.50K
2026-02-20Khan Ruhi AhmadBuy202.50K$1.80364.50K
2026-02-20Khan Ruhi AhmadBuy45.00K——
2026-02-20Albertson Tina M.Buy247.50K$1.80445.50K
2026-02-20Albertson Tina M.Buy55.00K——
2026-02-20Zheng RanBuy45.00K$1.8081.00K
2026-02-20Whiting NancyBuy45.00K$1.8081.00K
2026-02-20Sacks NatalieBuy45.00K$1.8081.00K
2026-02-20Richardson-Heron DaraBuy45.00K$1.8081.00K
2026-02-20JOHNSON DAVID LEEBuy45.00K$1.8081.00K
2026-02-20GUGGENHIME ANDREWBuy45.00K$1.8081.00K
2026-02-20Braunstein ScottBuy45.00K$1.8081.00K
2026-02-20Ryali SriramBuy247.50K$1.80445.50K
2026-02-20Ryali SriramBuy55.00K——
2026-02-20Haurwitz Rachel E.Buy682.50K$1.801.23M
2026-02-20Haurwitz Rachel E.Buy151.70K——
2025-03-14Haurwitz Rachel E.Buy20.00K$1.0220.40K
2025-02-21MCCLUNG BARBARA GSell3.56K$1.354.81K
2025-02-21Khan Ruhi AhmadSell3.56K$1.354.81K
2025-02-21Kanner StevenSell3.56K$1.354.81K
2025-02-20Haurwitz Rachel E.Buy618.25K$1.41871.73K
2025-02-20Haurwitz Rachel E.Buy136.75K——
2025-02-20Albertson Tina M.Buy66.14K$1.4193.25K
2025-02-20Albertson Tina M.Buy14.59K——
2025-02-20MCCLUNG BARBARA GBuy37.50K——
2025-02-20MCCLUNG BARBARA GBuy170.00K$1.41239.70K
2025-02-20Khan Ruhi AhmadBuy170.00K$1.41239.70K
2025-02-20Khan Ruhi AhmadBuy37.50K——
2025-02-20Kelly Timothy PBuy170.00K$1.41239.70K
2025-02-20Kelly Timothy PBuy37.50K——
2025-02-20Kanner StevenBuy37.50K——
2025-02-20Kanner StevenBuy170.00K$1.41239.70K
2025-02-20Zheng RanBuy40.50K$1.4157.10K
2025-02-20Whiting NancyBuy40.50K$1.4157.10K
2025-02-20Sacks NatalieBuy40.50K$1.4157.10K
2025-02-20Richardson-Heron DaraBuy40.50K$1.4157.10K
2025-02-20JOHNSON DAVID LEEBuy40.50K$1.4157.10K
2025-02-20GUGGENHIME ANDREWBuy40.50K$1.4157.10K
2025-02-20Braunstein ScottBuy40.50K$1.4157.10K
2025-01-29Ryali SriramBuy17.36K$1.4224.65K
2025-01-10Ryali SriramBuy300.00K$1.64492.00K
2025-01-02Ryali SriramOther0——
2024-11-20Fischesser RyanBuy25.00K——
2024-09-27Fischesser RyanOther0——
2024-09-27Fischesser RyanOther36.00K$6.81245.16K
2024-09-27Fischesser RyanOther13.06K$4.1153.70K
2024-09-27Fischesser RyanOther48.00K$6.12293.76K
2024-09-27Fischesser RyanOther40.00K$15.16606.40K
2024-08-19Albertson Tina M.Buy300.00K$2.18654.00K
2024-08-12Albertson Tina M.Other0——
2024-02-20O'Byrne JasonBuy153.00K$6.811.04M
2024-02-20O'Byrne JasonBuy33.00K——
2024-02-20MCCLUNG BARBARA GBuy33.00K——
2024-02-20MCCLUNG BARBARA GBuy153.00K$6.811.04M
2024-02-20Khan Ruhi AhmadBuy153.00K$6.811.04M
2024-02-20Khan Ruhi AhmadBuy33.00K——
2024-02-20Haurwitz Rachel E.Buy546.95K$6.813.72M
2024-02-20Haurwitz Rachel E.Buy118.70K——
2024-02-20Kanner StevenBuy33.00K——
2024-02-20Kanner StevenBuy153.00K$6.811.04M
2024-02-20Zheng RanBuy39.50K$6.81269.00K
2024-02-20Whiting NancyBuy39.50K$6.81269.00K
2024-02-20Sacks NatalieBuy39.50K$6.81269.00K
2024-02-20Richardson-Heron DaraBuy39.50K$6.81269.00K
2024-02-20JOHNSON DAVID LEEBuy39.50K$6.81269.00K
2024-02-20GUGGENHIME ANDREWBuy39.50K$6.81269.00K
2024-02-20Braunstein ScottBuy39.50K$6.81269.00K
2024-02-06Kanner StevenBuy30.58K$2.6982.25K
2024-02-06Kanner StevenSell30.58K$2.6982.25K
2024-01-08Kelly Timothy PBuy300.00K$5.741.72M
2024-01-01Kelly Timothy POther0——
2023-06-08Haurwitz Rachel E.Sell10.00K$2.9629.60K
2023-06-08Haurwitz Rachel E.Buy10.00K$2.9629.60K
2023-03-20Haurwitz Rachel E.Sell10.00K$2.9629.60K
2023-03-20Haurwitz Rachel E.Buy10.00K$2.9629.60K
2023-02-21Haurwitz Rachel E.Buy510.50K$6.123.12M
2023-02-21Kanner StevenBuy131.00K$6.12801.72K
2023-02-21Richardson-Heron DaraBuy21.50K$6.12131.58K
2023-02-21Khan Ruhi AhmadBuy131.00K$6.12801.72K
2023-02-21Sacks NatalieBuy21.50K$6.12131.58K
2023-02-21Braunstein ScottBuy21.50K$6.12131.58K
2023-02-21GUGGENHIME ANDREWBuy21.50K$6.12131.58K
2023-02-21MCCLUNG BARBARA GBuy131.00K$6.12801.72K
2023-02-21Rizvi Syed Ali-aamirBuy131.00K$6.12801.72K
2023-02-21Zheng RanBuy21.50K$6.12131.58K
2023-02-21Whiting NancyBuy21.50K$6.12131.58K
2023-02-21O'Byrne JasonBuy131.00K$6.12801.72K
2023-02-21JOHNSON DAVID LEEBuy21.50K$6.12131.58K
2023-01-19Rizvi Syed Ali-aamirSell5.63K$6.3135.51K
2022-12-02Kanner StevenBuy21.40K$2.6957.57K
2022-12-02Kanner StevenSell21.40K$2.6957.57K
2022-10-06Fischesser RyanBuy2.84K$4.1111.67K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 145, holders +3 vs prior quarter. Ownership 48.77%.

HolderSharesChangeChange %Value
BLACKROCK, INC.7.82M5.67M+264.70%13.76M
PFIZER INC4.69M00.00%7.88M
VANGUARD CAPITAL MANAGEMENT LLC4.21M441.34K+11.72%7.41M
MACKENZIE FINANCIAL CORP3.65M2.71M+287.23%6.43M
RENAISSANCE TECHNOLOGIES LLC2.77M183.05K+7.07%4.88M
KYNAM CAPITAL MANAGEMENT, LP2.50M00.00%4.41M
GEODE CAPITAL MANAGEMENT, LLC2.37M1.36M+133.30%4.18M
ACADIAN ASSET MANAGEMENT LLC1.77M849.43K+91.83%3.12M
STATE STREET CORP1.63M1.21M+285.79%2.87M
BANK OF AMERICA CORP /DE/1.41M113.79K+8.77%2.48M
TWO SIGMA INVESTMENTS, LP1.05M-713.65K-40.55%1.84M
DIMENSIONAL FUND ADVISORS LP975.33K302.13K+44.88%1.72M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC775.81K216.17K+38.63%1.37M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.775.81K775.81KNew1.37M
FMR LLC727.12K3.16K+0.44%1.28M
NORTHERN TRUST CORP712.97K495.23K+227.45%1.25M
MAVERICK CAPITAL LTD652.54K00.00%1.15M
VANGUARD PORTFOLIO MANAGEMENT LLC613.80K613.80KNew1.08M
VANGUARD FIDUCIARY TRUST CO606.39K86.27K+16.59%1.07M
QUBE RESEARCH & TECHNOLOGIES LTD545.75K369.06K+208.86%960.53K
UBS GROUP AG517.37K258.20K+99.63%910.57K
72 INVESTMENT HOLDINGS, LLC474.07K00.00%834.36K
GSA CAPITAL PARTNERS LLP463.42K-17.31K-3.60%816.00K
JACOBS LEVY EQUITY MANAGEMENT, INC410.98K52.04K+14.50%723.32K
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.382.41K-164.60K-30.09%673.00K

Earnings and financials

Caribou Biosciences, Inc. (CRBU) trades at $0.47, with a market cap of $50.89M and a trailing P/E of -0.44. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
57880001236100095980001385100034477000999400011159000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Caribou Biosciences (CRBU) Financials: Revenue & Earnings

CRBU$0.47+0.01 +3.04%

$50.89M

Market Cap

-0.44

P/E

—

Forward P/E

60

Score

Price History